Background and Aim: Living donor liver transplantation (LDLT) has particular advantages for Turkey where hepatitis B virus (HBV) infection is the most common cause of cirrhosis, both because LDLT ...
Combination therapy effective in HCV patients with advanced cirrhosis and post-transplant recurrence
Phase 3 results presented today at The International Liver Congress™ 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well ...
Ultrasound IDs Post-Transplant Recurrent Hep C Cirrhosis Ultrasound-based transient elastography detects cirrhosis from recurrent HCV after liver transplantation, but is less accurate for chronic ...
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...
Poor nutrition is common in patients with liver failure, or cirrhosis, and it can lead to muscle wasting, weakness, fatigue, and worse outcomes before and after patients undergo liver transplantation.
People under 45 have been driving an increase in liver-related deaths, especially those caused by alcohol. But a sliver of that young adult population is being hit disproportionately hard by ...
Cryptogenic cirrhosis is liver scarring that occurs without a known cause. It can cause fatigue, appetite loss, weight loss, swelling, and jaundice and may lead to irreversible liver damage. The liver ...
Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safety communication on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback